Profiel
Stephen Ronan Ferguson currently works at Medix Biochemica Oy Ab, as Chief Executive Officer from 2020, Medix Biochemica Group Oy, as Chief Executive Officer from 2020, and Diaclone SAS, as Chairman from 2021.
Actieve functies van Stephen Ronan Ferguson
| Bedrijven | Functie | Begin |
|---|---|---|
Medix Biochemica Oy Ab
 Medix Biochemica Oy Ab Medical SpecialtiesHealth Technology Medix Biochemica Oy Ab develops, produces, and markets monoclonal antibodies, antibody services, and recombinant antigens for in vitro diagnostics industry. It also provides rapid tests for human healthcare. The company was founded in 1985 and is headquartered in Espoo, Finland. | Algemeen Directeur | 01-01-2020 |
Diaclone SAS
 Diaclone SAS BiotechnologyHealth Technology Part of Medix Biochemica Group Oy, Diaclone SAS is a French company that specializes in clinical immunology and cell diagnoses. The company is based in Besançon, France. Diaclone was acquired by Medix Biochemica Oy Ab from Biotech Investissement SAS on July 13, 2021. | Voorzitter | 28-07-2021 |
Medix Biochemica Group Oy
 Medix Biochemica Group Oy BiotechnologyHealth Technology Medix Biochemica Group Oy engages in business and management consultancy activities. The company was founded on January 23, 2018 and is headquartered in Helsinki, Finland. | Algemeen Directeur | 01-01-2020 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Diaclone SAS
Diaclone SAS BiotechnologyHealth Technology Part of Medix Biochemica Group Oy, Diaclone SAS is a French company that specializes in clinical immunology and cell diagnoses. The company is based in Besançon, France. Diaclone was acquired by Medix Biochemica Oy Ab from Biotech Investissement SAS on July 13, 2021. | Health Technology |
Medix Biochemica Oy Ab
Medix Biochemica Oy Ab Medical SpecialtiesHealth Technology Medix Biochemica Oy Ab develops, produces, and markets monoclonal antibodies, antibody services, and recombinant antigens for in vitro diagnostics industry. It also provides rapid tests for human healthcare. The company was founded in 1985 and is headquartered in Espoo, Finland. | Health Technology |
Medix Biochemica Group Oy
Medix Biochemica Group Oy BiotechnologyHealth Technology Medix Biochemica Group Oy engages in business and management consultancy activities. The company was founded on January 23, 2018 and is headquartered in Helsinki, Finland. | Health Technology |